tiprankstipranks
Trending News
More News >
Innovent Biologics (HK:1801)
:1801
Hong Kong Market

Innovent Biologics (1801) Cash flow

Compare
10 Followers

Innovent Biologics Cash Flow

HK:1801's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, HK:1801's free cash flow was decreased by ¥1.24B and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 0.00¥ 147.81M¥ -1.92B¥ -2.02B¥ -307.69M
Investing Cash Flow
¥ 0.00¥ -998.66M¥ -1.44B¥ -2.70B¥ -5.18B
Financing Cash Flow
¥ 0.00¥ 2.59B¥ 2.89B¥ 5.00B¥ 4.91B
End Cash Position
¥ 0.00¥ 2.75B¥ 1.02B¥ 1.36B¥ 1.28B
Free Cash Flow
¥ 0.00¥ -1.24B¥ -3.30B¥ -3.87B¥ -1.08B
Currency in CNY

Innovent Biologics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis